Nephros Ownership 2024 | Who Owns Nephros Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

41.14%

Insider Ownership

12.75%

Retail Ownership

46.11%

Institutional Holders

18.00

Nephros Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WEXFORD CAPITAL LP34.29%1.93%3,600,552--7,640,152Jun 30, 2024
VANGUARD GROUP INC1.85%-194,02418,37510.46%409,391Jun 30, 2024
BARD ASSOCIATES INC1.67%0.14%175,596-3,780-2.11%370,508Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.74%-78,0356,9989.85%164,693Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.54%0.00%57,210-1,000-1.72%121,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.39%0.00%41,000-200-0.49%86,510Jun 30, 2024
BLAIR WILLIAM & CO/IL0.35%0.00%36,249--76,485Jun 30, 2024
ELKHORN PARTNERS LIMITED PARTNERSHIP0.34%0.05%36,000--76,000Jun 30, 2024
UBS GROUP AG0.18%-19,35819,0516205.54%40,845Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-17,63117,631100.00%37,201Jun 30, 2024
STATE STREET CORP0.15%-15,698--33,123,000Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.13%0.00%13,9739267.10%29,483Jun 30, 2024
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC.0.13%0.00%13,800-1,583-10.29%29,118Jun 30, 2024
MORGAN STANLEY0.05%-5,423--11,443Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,673-728-16.54%7,750Jun 30, 2024
JPMORGAN CHASE & CO0.00%-22210.45%469Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-7676100.00%160Jun 30, 2024
WELLS FARGO & COMPANY/MN----73-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----11,617-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----36-100.00%-Jun 30, 2024

Nephros's largest institutional shareholder is WEXFORD CAPITAL LP, holding 34.29% of the company's total share outstanding, currently valued at $7.64M. The top 10 institutional shareholders own together 40.52% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WEXFORD CAPITAL LP34.29%1.93%3,600,552--7,640,152Jun 30, 2024
BARD ASSOCIATES INC1.67%0.14%175,596-3,780-2.11%370,508Jun 30, 2024
ELKHORN PARTNERS LIMITED PARTNERSHIP0.34%0.05%36,000--76,000Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.13%0.00%13,9739267.10%29,483Jun 30, 2024
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC.0.13%0.00%13,800-1,583-10.29%29,118Jun 30, 2024
BLAIR WILLIAM & CO/IL0.35%0.00%36,249--76,485Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.54%0.00%57,210-1,000-1.72%121,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.39%0.00%41,000-200-0.49%86,510Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,673-728-16.54%7,750Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.74%-78,0356,9989.85%164,693Jun 30, 2024
UBS GROUP AG0.18%-19,35819,0516205.54%40,845Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-17,63117,631100.00%37,201Jun 30, 2024
VANGUARD GROUP INC1.85%-194,02418,37510.46%409,391Jun 30, 2024
STATE STREET CORP0.15%-15,698--33,123,000Jun 30, 2024
MORGAN STANLEY0.05%-5,423--11,443Jun 30, 2024
JPMORGAN CHASE & CO0.00%-22210.45%469Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-7676100.00%160Jun 30, 2024
WELLS FARGO & COMPANY/MN----73-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----11,617-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----36-100.00%-Jun 30, 2024

The largest Nephros shareholder by % of total assets is WEXFORD CAPITAL LP. The company owns 3.60M shares of Nephros (NEPH), representing 1.93% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.18%-19,35819,0516205.54%40,845Jun 30, 2024
VANGUARD GROUP INC1.85%-194,02418,37510.46%409,391Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-17,63117,631100.00%37,201Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.74%-78,0356,9989.85%164,693Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.13%0.00%13,9739267.10%29,483Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-7676100.00%160Jun 30, 2024
JPMORGAN CHASE & CO0.00%-22210.45%469Jun 30, 2024
MORGAN STANLEY0.05%-5,423--11,443Jun 30, 2024
STATE STREET CORP0.15%-15,698--33,123,000Jun 30, 2024
BLAIR WILLIAM & CO/IL0.35%0.00%36,249--76,485Jun 30, 2024
ELKHORN PARTNERS LIMITED PARTNERSHIP0.34%0.05%36,000--76,000Jun 30, 2024
WEXFORD CAPITAL LP34.29%1.93%3,600,552--7,640,152Jun 30, 2024
NEWEDGE ADVISORS, LLC----36-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----73-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.39%0.00%41,000-200-0.49%86,510Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,673-728-16.54%7,750Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.54%0.00%57,210-1,000-1.72%121,000Jun 30, 2024
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC.0.13%0.00%13,800-1,583-10.29%29,118Jun 30, 2024
BARD ASSOCIATES INC1.67%0.14%175,596-3,780-2.11%370,508Jun 30, 2024
TWO SIGMA SECURITIES, LLC----11,617-100.00%-Jun 30, 2024

As of Jun 30 2024, Nephros's largest institutional buyer is UBS GROUP AG. The company purchased 19.05K stocks of NEPH, valued at $40.84K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC----11,617-100.00%-Jun 30, 2024
BARD ASSOCIATES INC1.67%0.14%175,596-3,780-2.11%370,508Jun 30, 2024
MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC.0.13%0.00%13,800-1,583-10.29%29,118Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.54%0.00%57,210-1,000-1.72%121,000Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,673-728-16.54%7,750Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.39%0.00%41,000-200-0.49%86,510Jun 30, 2024
WELLS FARGO & COMPANY/MN----73-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----36-100.00%-Jun 30, 2024
WEXFORD CAPITAL LP34.29%1.93%3,600,552--7,640,152Jun 30, 2024
ELKHORN PARTNERS LIMITED PARTNERSHIP0.34%0.05%36,000--76,000Jun 30, 2024
BLAIR WILLIAM & CO/IL0.35%0.00%36,249--76,485Jun 30, 2024
STATE STREET CORP0.15%-15,698--33,123,000Jun 30, 2024
MORGAN STANLEY0.05%-5,423--11,443Jun 30, 2024
JPMORGAN CHASE & CO0.00%-22210.45%469Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-7676100.00%160Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.13%0.00%13,9739267.10%29,483Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.74%-78,0356,9989.85%164,693Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-17,63117,631100.00%37,201Jun 30, 2024
VANGUARD GROUP INC1.85%-194,02418,37510.46%409,391Jun 30, 2024
UBS GROUP AG0.18%-19,35819,0516205.54%40,845Jun 30, 2024

As of Jun 30 2024, Nephros's biggest institutional seller is TWO SIGMA SECURITIES, LLC. The company sold -11.62K shares of NEPH, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DIMENSIONAL FUND ADVISORS LP0.17%-17,63117,631100.00%37,201Jun 30, 2024

Nephros's largest new institutional shareholder by number of shares is DIMENSIONAL FUND ADVISORS LP, purchased 17.63K shares, valued at $37.20K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC----11,617-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----73-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----36-100.00%-Jun 30, 2024

Nephros's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -11.62K shares, valued at -, as of undefined.

Nephros Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INDEX FUNDS0.00%175,649-64,866-26.97%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%69,458-360-0.52%Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%5,363--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%3,1452,245249.44%Jan 31, 2024
EQ ADVISORS TRUST0.00%1,163--Mar 31, 2024
iSHARES TRUST0.00%4,131--Mar 31, 2024

Nephros's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 175.65K shares, compromising 0.00% of its total assets.

Nephros Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2418-
31 Mar, 2418-
31 Dec, 231828.57%
30 Sep, 2314-6.67%
30 Jun, 2315-11.76%
31 Mar, 2317-5.56%
31 Dec, 22185.88%
30 Sep, 22176.25%
30 Jun, 221614.29%
31 Mar, 22147.69%
31 Dec, 2113-13.33%
30 Sep, 2115-11.76%
30 Jun, 2117-
31 Mar, 211721.43%
31 Dec, 2014-6.67%
30 Sep, 2015-16.67%
30 Jun, 2018-10.00%
31 Mar, 202053.85%
31 Dec, 191385.71%
30 Sep, 197-

As of 30 Jun 24, 18 institutions are holding Nephros's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 244,320,3681.31%
31 Mar, 244,264,479-1.55%
31 Dec, 234,331,8331.00%
30 Sep, 234,288,9600.21%
30 Jun, 234,279,8080.15%
31 Mar, 234,273,1880.16%
31 Dec, 224,266,476-1.68%
30 Sep, 224,339,5001.21%
30 Jun, 224,287,628-0.45%
31 Mar, 224,307,145-17.20%
31 Dec, 215,201,569205.84%
30 Sep, 211,700,762-71.26%
30 Jun, 215,916,97013.11%
31 Mar, 215,231,378-0.96%
31 Dec, 205,282,30618.05%
30 Sep, 204,474,719-1.55%
30 Jun, 204,545,3233.80%
31 Mar, 204,378,807854.77%
31 Dec, 19458,62677.68%
30 Sep, 19258,124-

Nephros (NEPH) has 4.32M shares outstanding as of 30 Jun 24, up 1.31% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2441.14%2.51%
31 Mar, 2440.45%2.36%
31 Dec, 2341.41%2.39%
30 Sep, 2341.65%2.41%
30 Jun, 2341.56%2.41%
31 Mar, 2341.50%2.42%
31 Dec, 2241.43%2.34%
30 Sep, 2242.12%2.43%
30 Jun, 2241.63%2.34%
31 Mar, 2242.17%1.56%
31 Dec, 2151.92%18.11%
30 Sep, 2116.93%0.48%
30 Jun, 2159.51%2.12%
31 Mar, 2152.93%1.55%
31 Dec, 2058.43%2.38%
30 Sep, 2049.50%1.93%
30 Jun, 2050.58%1.95%
31 Mar, 2050.97%178.83%
31 Dec, 195.34%47.55%
30 Sep, 193.35%-

As of 30 Jun 24, Nephros is held by 41.14% institutional shareholders, representing a 2.51% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 248-27.27%
31 Mar, 241110.00%
31 Dec, 2310150.00%
30 Sep, 234-
30 Jun, 234100.00%
31 Mar, 232-60.00%
31 Dec, 225-44.44%
30 Sep, 229-
30 Jun, 229-
31 Mar, 22980.00%
31 Dec, 215-37.50%
30 Sep, 218-11.11%
30 Jun, 219-18.18%
31 Mar, 211137.50%
31 Dec, 20860.00%
30 Sep, 205-28.57%
30 Jun, 207-50.00%
31 Mar, 201455.56%
31 Dec, 19928.57%
30 Sep, 197-

8 institutional shareholders have increased their position in NEPH stock as of 30 Jun 24 compared to 11 in the previous quarter (a -27.27% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24566.67%
31 Mar, 24350.00%
31 Dec, 232-33.33%
30 Sep, 233-40.00%
30 Jun, 235-28.57%
31 Mar, 23775.00%
31 Dec, 224100.00%
30 Sep, 222-60.00%
30 Jun, 225150.00%
31 Mar, 222-50.00%
31 Dec, 214100.00%
30 Sep, 212-60.00%
30 Jun, 215150.00%
31 Mar, 212-50.00%
31 Dec, 204-20.00%
30 Sep, 20525.00%
30 Jun, 20433.33%
31 Mar, 20350.00%
31 Dec, 192-
30 Sep, 19--

5 institutional shareholders have reduced their position in NEPH stock as of 30 Jun 24 compared to 3 in the previous quarter (a 66.67% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2418-4,320,3681.31%41.14%2.51%8-27.27%566.67%
31 Mar, 2418-4,264,479-1.55%40.45%2.36%1110.00%350.00%
31 Dec, 231828.57%4,331,8331.00%41.41%2.39%10150.00%2-33.33%
30 Sep, 2314-6.67%4,288,9600.21%41.65%2.41%4-3-40.00%
30 Jun, 2315-11.76%4,279,8080.15%41.56%2.41%4100.00%5-28.57%
31 Mar, 2317-5.56%4,273,1880.16%41.50%2.42%2-60.00%775.00%
31 Dec, 22185.88%4,266,476-1.68%41.43%2.34%5-44.44%4100.00%
30 Sep, 22176.25%4,339,5001.21%42.12%2.43%9-2-60.00%
30 Jun, 221614.29%4,287,628-0.45%41.63%2.34%9-5150.00%
31 Mar, 22147.69%4,307,145-17.20%42.17%1.56%980.00%2-50.00%
31 Dec, 2113-13.33%5,201,569205.84%51.92%18.11%5-37.50%4100.00%
30 Sep, 2115-11.76%1,700,762-71.26%16.93%0.48%8-11.11%2-60.00%
30 Jun, 2117-5,916,97013.11%59.51%2.12%9-18.18%5150.00%
31 Mar, 211721.43%5,231,378-0.96%52.93%1.55%1137.50%2-50.00%
31 Dec, 2014-6.67%5,282,30618.05%58.43%2.38%860.00%4-20.00%
30 Sep, 2015-16.67%4,474,719-1.55%49.50%1.93%5-28.57%525.00%
30 Jun, 2018-10.00%4,545,3233.80%50.58%1.95%7-50.00%433.33%
31 Mar, 202053.85%4,378,807854.77%50.97%178.83%1455.56%350.00%
31 Dec, 191385.71%458,62677.68%5.34%47.55%928.57%2-
30 Sep, 197-258,124-3.35%-7---

Nephros Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy3,000$2.24$6.73K103,463
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy2,000$2.22$4.44K100,463
May 16, 2024Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy50,000$2.24$112.05K70,000
Mar 14, 2024Amron Arthur Hdirector-P-PurchaseBuy7,000$2.45$17.13K7,000
Dec 11, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy18,000$2.20$39.65K20,000
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy1,901$1.69$3.21K2,000
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy99$1.50$148.5099

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy3,000$2.24$6.73K103,463
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy2,000$2.22$4.44K100,463
May 16, 2024Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy50,000$2.24$112.05K70,000
Mar 14, 2024Amron Arthur Hdirector-P-PurchaseBuy7,000$2.45$17.13K7,000
Dec 11, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy18,000$2.20$39.65K20,000
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy1,901$1.69$3.21K2,000
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy99$1.50$148.5099

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 14, 2024WEXFORD CAPITAL LP10 percent owner-J-OtherSell91,463--56,060

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy3,000$2.24$6.73K103,463
May 30, 2024Amron Arthur Hdirector-P-PurchaseBuy2,000$2.22$4.44K100,463
May 16, 2024Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy50,000$2.24$112.05K70,000
May 16, 2024Banks Robert R. Jr.director, officer President and CEOA-AwardBuy10,406$2.14$22.27K10,406
May 16, 2024Amron Arthur Hdirector-A-AwardBuy7,323$2.14$15.67K7,323
May 16, 2024Lask Alisadirector-A-AwardBuy7,323$2.14$15.67K7,323
May 16, 2024Spandow Oliver J.director-A-AwardBuy7,323$2.14$15.67K7,323
May 16, 2024Harris Joseph Michaeldirector-A-AwardBuy7,323$2.14$15.67K7,323
Mar 14, 2024WEXFORD CAPITAL LP10 percent owner-J-OtherSell91,463--56,060
Mar 14, 2024Amron Arthur Hdirector-J-OtherBuy91,463--98,463
Mar 14, 2024Amron Arthur Hdirector-P-PurchaseBuy7,000$2.45$17.13K7,000
Dec 15, 2023Spandow Oliver J.director-A-AwardBuy14,294--81,604
Dec 15, 2023Lask Alisadirector-A-AwardBuy9,291--48,629
Dec 15, 2023Harris Joseph Michaeldirector-A-AwardBuy9,291--17,693
Dec 15, 2023Amron Arthur Hdirector-A-AwardBuy9,291--9,291
Dec 11, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy18,000$2.20$39.65K20,000
Nov 03, 2023Krandel Judyofficer Chief Financial OfficerA-AwardBuy122,524$1.71$209.52K122,524
Nov 03, 2023Krandel Judyofficer-Buy----
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy1,901$1.69$3.21K2,000
Aug 15, 2023Banks Robert R. Jr.director, officer President and CEOP-PurchaseBuy99$1.50$148.5099

The last insider sell of Nephros's stock was made by WEXFORD CAPITAL LP on Mar 14 2024, selling 91,463 shares at - per share (valued at -). The last insider buy of NEPH was made by Amron Arthur H on May 30 2024, buying 3,000 shares at $2.24 per share (worth $6.73K).

Nephros Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20248--
Q1 202421200.00%
Q4 20236--
Q3 20232--
Q2 2023-1-
Q1 202310--
Q3 20221--
Q1 20221333.33%
Q4 20219--
Q3 20215--
Q2 20213475.00%
Q1 2021174425.00%
Q4 202031300.00%
Q3 20202--
Q2 202021200.00%
Q1 20207--
Q4 201919--
Q3 20196--
Q2 20197--
Q1 20192--

8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Nephros's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20243--
Q1 20241--
Q4 20231--
Q3 20232--
Q2 2023---
Q1 2023---
Q3 2022---
Q1 2022---
Q4 2021---
Q3 20214--
Q2 2021---
Q1 2021---
Q4 20202--
Q3 20201--
Q2 20201--
Q1 20204--
Q4 20193--
Q3 20193--
Q2 20196--
Q1 2019---

As of Q2 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Nephros's stocks.

Nephros Peer Ownership


TickerCompany
KRMDKORU Medical Systems, Inc.
POCIPrecision Optics Corporation, Inc.
PDEXPro-Dex, Inc.
UTMDUtah Medical Products, Inc.

NEPH Ownership FAQ


Nephros is owned by institutional shareholders (41.14%), insiders (12.75%), and public (46.11%). The largest institutional shareholder of Nephros is WEXFORD CAPITAL LP (34.29% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Nephros's major institutional shareholders are WEXFORD CAPITAL LP, VANGUARD GROUP INC, BARD ASSOCIATES INC, GEODE CAPITAL MANAGEMENT, LLC, and HIGHTOWER ADVISORS, LLC. The top five shareholders own together 39.09% of the company's share outstanding.

As of Jun 2024, there are 18 institutional shareholders of Nephros.

WEXFORD CAPITAL LP owns 3.6M shares of Nephros, representing 34.29% of the company's total shares outstanding, valued at $7.64M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 194.02K shares of Nephros (NEPH), compromising 1.85% of the company, valued at $409.39K.

BARD ASSOCIATES INC is the third largest holder of Nephros. The company owns 175.6K of the company's shares outstanding (worth $370.51K).